• Wockhardt is an Indian domestic pharma company. • AstraZeneca is an MNC company in India doing well. • Whichever is domestic Indian pharma companies, Dr. Reddy, CIPLA, etc are focusing more on export business. Due to export, only these companies are having grown in the last 12-15 years. • Abbott India Limited and Astrazeneca have limited performance domestically, • But in MNC Pharma companies the problem is Pharma products are not allowed to be launched in India. Also, There are a lot of processes in MNC pharma to launch it in India. • So the products are of these MNCs are of good quality. • Domestic Pharma Company may witness good growth in the case of acquisition and a decent export share as well.